Warfarin dose requirements in a patient with the CYP2C9*14 allele

Lignende værker

• Decreased Warfarin Clearance with the CYP2C9 R150H (*8) Polymorphism
  af: Liu, Yong, et al.
  Udgivet: (2012)
• CYP2C9 polymorphism and warfarin dose requirements
  af: Daly, Ann K, et al.
  Udgivet: (2002)
• Poor Warfarin Dose Prediction with Pharmacogenetic Algorithms that Exclude Genotypes Important for African Americans
  af: Drozda, Katarzyna, et al.
  Udgivet: (2015)
• Anticoagulation Endpoints with Clinical Implementation of Warfarin Pharmacogenetic Dosing in a Real-World Setting – A Proposal for a New Pharmacogenetic Dosing Approach
  af: Arwood, Meghan J., et al.
  Udgivet: (2016)
• Factors influencing pharmacokinetics of warfarin in African–Americans: implications for pharmacogenetic dosing algorithms
  af: Nagai, Rui, et al.
  Udgivet: (2015)